Universal Ibogaine Inc.
IBO.V
TSX
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
2/26/2025
-
Globe Newswire
1/23/2025
-
Globe Newswire
11/19/2024
-
Globe Newswire
10/15/2024
-
Globe Newswire
10/7/2024
-
Globe Newswire
9/26/2024
-
Globe Newswire
9/23/2024
-
Globe Newswire
9/17/2024
-
Globe Newswire
9/16/2024
-
Globe Newswire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, June 28, 2024
Period Date
Sunday, March 31, 2024
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
855-426-4246
Address
815 8th Avenue SW
Calgary, AB T2P 3P2
Calgary, AB T2P 3P2
Country
Year Founded
--
Business Description
Sector
Industry
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of...
more
